Premium
An evaluation of the cross‐protection afforded by inactivated infectious coryza vaccines
Author(s) -
BLACKALL PJ
Publication year - 1991
Publication title -
australian veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.382
H-Index - 59
eISSN - 1751-0813
pISSN - 0005-0423
DOI - 10.1111/j.1751-0813.1991.tb03237.x
Subject(s) - virology , biology , medicine
SUMMARY The cross‐protection afforded by three inactivated infectious coryza vaccines was evaluated. Each vaccine contained one of the following strains of Haemophilus paragallinarum , HP31, HP60 and HP14. Strain HP31 belongs to Kume serovar C‐2, strain HP60 belongs to Kume serovar C‐4 while strain HP14 belongs to Kume serovar A‐4. Four groups of twenty six‐week‐old specific‐pathogen‐free chickens were either given a single dose of an aluminium‐hydroxide based vaccine (three groups) or left as unvaccinated controls. Three weeks after vaccination, all four groups were challenged with virulent H paragallinarum. One half of each group was challenged with the strain HP31 and the other half with strain HP60. The efficacy of the vaccines was assessed in terms of the prevention of the typical clinical signs and macroscopic lesions of infectious coryza as well as the prevention of any colonisation by the challenge organism. The serovar C‐2 and serovar C‐4 vaccines protected more than 50% of birds against either a serovar C‐2 or C‐4 challenge while the serovar A‐4 vaccine protected less than 50% of birds.